Exclusive enteral nutrition containing transforming growth factor‐β improves intestinal barrier function in a colitis mouse model
Journal of Pediatric Gastroenterology and Nutrition · 21.07.2026
DOI: 10.1002/jpn3.70517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 21.07.2026. Verfasst von Kawthar Boumessid und 6 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR1220, INRAE, ENVT, University of Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Intestinal Barrier Function, Colitis, Transforming Growth Factor beta, Enteral Nutrition. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: INSERM, Direction Générale de l'offre de Soins, ROTARY Club of Portet sur Garonne.
Abstract (Originalsprache)
Objectives
Exclusive enteral nutrition (EEN) is the first‐line treatment for pediatric Crohn's disease, but its mechanisms of action remain poorly understood. Our aim was to identify the mechanisms that could explain the anti‐inflammatory effects of EEN, studying the nutritional composition and transforming growth factor‐β (TGF‐β) effects, in a mouse model of colitis.
Methods
Mice were treated with dextran sulfate sodium (DSS) to induce colitis. After DSS treatment, we compared two enteral nutrition formulas, and we evaluated the effect of TGF‐β itself on clinical and microscopic inflammation, and intestinal permeability, by TGF‐β‐supplementation, ‐inhibition, or ‐deletion. Colonic crypts from DSS and EEN mice were cultured and their cellular properties were analyzed.
Results
Both EEN formulas improved weight recovery and disease activity index. In contrast, EEN mice treated with TGF‐β formula presented faster weight recovery and decreased inflammatory parameters, with a normalized intestinal permeability, suggesting gut restitution and functionality. These functional improvements were not found in the absence of TGF‐β in the formulas. Finally, organoids from colonic crypts treated with Modulen IBD® containing TGF‐β showed enhanced survival and re‐epithelialization capacity.
Conclusions
Both EEN formulas have anti‐inflammatory properties based on their nutritional composition. However, TGF‐β plays a significant role in intestinal functional restitution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM UMR1220, INRAE, ENVT, University of Toulouse, Toulouse, France.
- Gastroenterology, Hepatology, Nutrition, Diabetes and Inborn Errors of Metabolism Department, Children Hospital, Toulouse University Hospital, Toulouse, France.
- UMR 938, Research Center of Saint-Antoine, Sorbonne University, INSERM, Paris, France.
- EPHE, PSL University, Paris, France.
- SyMMES, University of Grenoble, CEA, INP, CNRS, Grenoble, France.
ORCID-Profile: Frédérick Barreau, Emmanuel Mas
Förderung
- INSERM
- Direction Générale de l'offre de Soins
- ROTARY Club of Portet sur Garonne
Zitieren
APA
Boumessid, K., Lacroix, V., Ovtchinnikova, E., Thenet, S., Carriere, M., Barreau, F., & Mas, E. (2026). Exclusive enteral nutrition containing transforming growth factor‐β improves intestinal barrier function in a colitis mouse model. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70517
Vancouver
Boumessid K, Lacroix V, Ovtchinnikova E, Thenet S, Carriere M, Barreau F, et al. Exclusive enteral nutrition containing transforming growth factor‐β improves intestinal barrier function in a colitis mouse model. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70517
BibTeX
@article{Boumessid2026,
author = {Boumessid, Kawthar and Lacroix, Vickie and Ovtchinnikova, Ekaterina and Thenet, Sophie and Carriere, Marie and Barreau, Frédérick and Mas, Emmanuel},
title = {Exclusive enteral nutrition containing transforming growth factor‐β improves intestinal barrier function in a colitis mouse model},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70517}
}
EUVIMED